Health
Insulin Cap Proposal in U.S. Senate
U.S. senators are considering capping the cost of insulin at $35 for private insurance and the uninsured to address affordability issues. The proposal aims to make insulin more accessible.
Coverage timeline — 1 article
STAT News
The search for affordability wins is leading U.S. senators back to capping the cost of insulin at $35 in the private insurance market and for the uninsured
2026-06-29 13:07 UTC